Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Teprotumumab on Thyroid Eye Disease and Thyroid Dysfunction

NCT06275373 is registered in ClinicalTrials.gov with Walter Reed National Military Medical Center as lead sponsor.

NCT NCT06275373
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06275373 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Teprotumumab on Thyroid Eye Disease and Thyroid Dysfunction
Lead sponsor
Walter Reed National Military Medical Center
Phase
Observational
Overall status
Recruiting
Start date
May 12, 2021
Completion date
December 12, 2027
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

graves disease, graves ophthalmopathy, thyroid eye disease